Abstract
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease that lacks sensitive and specific diagnostic methods. The aim of this study was to identify potential biomarkers specific for pSS and to establish a diagnostic model. Serum samples from patients with pSS, disease controls (DC, patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA)), and healthy controls (HC)) were randomly divided into a training set (35 pSS, 50 DC, and 26 HC) and a testing set (25 pSS, 50 DC, and 25 HC). Weak cationic exchange (WCX) magnetic beads were used to differentially capture serum proteins prior to proteomic analysis. Proteomic mass spectra were generated by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). One hundred differential M/Z peaks associated with pSS were identified, and the m/z peaks at 8,133.85, 11,972.8, 2,220.81, and 4,837.66 were used to establish a diagnostic model for pSS. This diagnostic model was able to distinguish pSS from non-pSS controls with a sensitivity of 77.1 % and a specificity of 85.5 %, and its efficacy was confirmed in our blinded testing set with good sensitivity and specificity of 95.5 and 88 %, respectively. The results indicated that the proteomic fingerprinting model was effective in the diagnosis of pSS.
Similar content being viewed by others
References
Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum 46(3):741–7
Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum 29(5):296–304
Theander E, Manthorpe R, Jacobsson LT (2004) Mortality and causes of death in primary Sjögren’s syndrome: a prospective cohort study. Arthritis Rheum 50(4):1262–9
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–8
Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T, Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups (2012) American college of rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken) 64(4):475–87
Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol 21(5):656–60
Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG (2014) A comprehensive review of autoantibodies in primary Sjögren’s syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun 51C:67–74. doi:10.1016/j.jaut.2013.11.001
de Noo ME, Mertens BJ, Ozalp A, Bladergroen MR, van der Werff MP, van de Velde CJ, Deelder AM, Tollenaar RA (2006) Detection of colorectal cancer using MALDI-TOF serum protein profiling. Eur J Cancer 42(8):1068–1076
Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JT, Wang HM, Liao CT, Chen IH (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51(12):2236–44
Peter JF, Otto AM, Wolf B (2007) Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particle and LC-MALDI-TOF-MS. J Biomol Tech 18(5):287–297
Long L, Li R, Li Y, Hu C, Li Z (2011) Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting. Rheumatol Int 31(8):1069–74. doi:10.1007/s00296-010-1407-4
Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359(9306):572–7
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. J Ann Rheum Dis 69(9):1580–1588
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):p. 1725
Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR (2008) Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and post-treatment head and neck cancer samples. Laryngoscope 118(1):61–8
Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McLeod DG, Moul JW, Srivastava S (2003) Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 170(2 pt 1):442–6
Beeley JA, Khoo KS (1999) Salivary proteins in rheumatoid arthritis and Sjögren’s syndrome: one-dimensional and two-dimensional electrophoretic studies. Electrophoresis 20(7):1652–1660
Tomosugi N, Kitagawa K, Takahashi N, Sugai S, Ishikawa I (2005) Diagnostic potential of tear proteomic patterns in Sjögren’s syndrome. J Proteome Res 4(3):820–825
Ryu OH, Arkinson JC, Hoehn GT, Illei GG, Hart TC (2006) Identification of parotid salivary biomarkers in Sjögren’s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 45(9):1077–1086
Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, Mascia G, Giannaccini G, Bombardieri S, Lucacchini A (2007) Proteome analysis of whole saliva: a new tool for rheumatic diseases–the example of Sjögren’s syndrome. Proteomic 7(10):1634–1643
Srea EA, Routsias JG, Samiotaki M, Panayotou G, Papalambros E, Moutsopoulos HM, Tzioufas AG (2007) Analysis of parotid glands of primary Sjögren’s syndrome patients using proteomic technology reveals altered autoantigen compositon and novel antigenic targets. Clin Exp Immunol 147(1):81–89
Peluso G, De Santis M, Inzitari C, Fanali C, Cabras T, Messana I, Castagnola M, Ferraccioli GF (2007) Proteomic study of salivary peptides and proteins in patients with Sjögren’s syndrome before and after pilocarpine treatment. Arthritis Rheum 56(7):2216–2222
Zoukhri D, Rawe I, Singh M, Brown A, Kublin CL, Dawson K, Haddon WF, White EL, Hanley KM, Tusé D, Malyj W, Papas A (2012) Discovery of putative salivary biomarkers for Sjögren’s syndrome using high resolution mass spectrometry and bioinformatics. J Oral Sci 54(1):61–70
Wei P, Kuo WP, Chen F, Hua H (2013) Diagnostic model of saliva peptide finger print analysis of primary Sjögren’s syndrome patients by using weak cation exchange magnetic beads. Biosci Rep 16(4):e00051. doi:10.1042/BSR20130022
Acknowledgment
This work was supported by grants from the National Sci-Tech Support Program (2014BAI07B01), Beijing Municipal Science & Technology Commission (Z141107002514064), National Natrual Science Foundation of China (81273292, 81202343) and Research and Development Fund of Peking University People’s Hospital (RDB2014-03, RDB2014-04).
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 143 kb)
Rights and permissions
About this article
Cite this article
Li, Y., Sun, X., Zhang, X. et al. Establishment of a novel diagnostic model for Sjögren’s syndrome by proteomic fingerprinting. Clin Rheumatol 33, 1745–1750 (2014). https://doi.org/10.1007/s10067-014-2762-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2762-4